Phosphoinositide 3-kinase: From viral oncoprotein to drug target

Virology

Volumn 344, Issue 1, 2006, Pages 131-138

  Vogt, Peter K ^a   Bader, Andreas G ^a   Kang, Sohye ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN;

AVIAN SARCOMA VIRUS; CARCINOGENESIS; DRUG TARGETING; ENZYME ACTIVITY; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETROVIRUS; REVIEW; RNA TRANSLATION; SEQUENCE HOMOLOGY; VIRUS REPLICATION; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AVIAN SARCOMA VIRUSES; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; HUMANS; ISOENZYMES; MUTATION; ONCOGENE PROTEIN V-AKT; ONCOGENE PROTEINS; PROTEIN KINASES; SIROLIMUS;

AVIAN SARCOMA VIRUS;

EID: 29144433991     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.09.027     Document Type: Review

References (103)

1. D.R. Alessi, S.R. James, C.P. Downes, A.B. Holmes, P.R. Gaffney, C.B. Reese, and P. Cohen Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha Curr. Biol. 7 4 1997 261 269
2. I.U. Ali, L.M. Schriml, and M. Dean Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity J. Natl. Cancer Inst. 91 22 1999 1922 1932
3. K.E. Anderson, J. Coadwell, L.R. Stephens, and P.T. Hawkins Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B Curr. Biol. 8 12 1998 684 691
4. M. Andjelkovic, D.R. Alessi, R. Meier, A. Fernandez, N.J. Lamb, M. Frech, P. Cron, P. Cohen, J.M. Lucocq, and B.A. Hemmings Role of translocation in the activation and function of protein kinase B J. Biol. Chem. 272 50 1997 31515 31524
5. M. Aoki, O. Batista, A. Bellacosa, P. Tsichlis, and P.K. Vogt The akt kinase: molecular determinants of oncogenicity Proc. Natl. Acad. Sci. U.S.A. 95 25 1998 14950 14955
6. M. Aoki, C. Schetter, M. Himly, O. Batista, H.W. Chang, and P.K. Vogt The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity J. Biol. Chem. 275 9 2000 6267 6275
7. M. Aoki, E. Blazek, and P.K. Vogt A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt Proc. Natl. Acad. Sci. U.S.A. 98 1 2001 136 141
8. K.E. Bachman, P. Argani, Y. Samuels, N. Silliman, J. Ptak, S. Szabo, H. Konishi, B. Karakas, B.G. Blair, C. Lin, B.A. Peters, V.E. Velculescu, and B.H. Park The PIK3CA gene is mutated with high frequency in human breast cancers Cancer Biol. Ther. 3 8 2004 772 775
9. S.S. Bacus, D.A. Altomare, L. Lyass, D.M. Chin, M.P. Farrell, K. Gurova, A. Gudkov, and J.R. Testa AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival Oncogene 21 22 2002 3532 3540
10. A.G. Bader, and P.K. Vogt Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation Mol. Cell. Biol. 25 6 2005 2095 2106
11. A.G. Bader, K.A. Felts, N. Jiang, H.W. Chang, and P.K. Vogt Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway Proc. Natl. Acad. Sci. U.S.A. 100 21 2003 12384 12389
12. A. Balendran, A. Casamayor, M. Deak, A. Paterson, P. Gaffney, R. Currie, C.P. Downes, and D.R. Alessi PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2 Curr. Biol. 9 8 1999 393 404
13. B.R. Balsara, J. Pei, Y. Mitsuuchi, R. Page, A. Klein-Szanto, H. Wang, M. Unger, and J.R. Testa Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions Carcinogenesis 25 11 2004 2053 2059
14. A. Bellacosa, J.R. Testa, S.P. Staal, and P.N. Tsichlis A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region Science 254 5029 1991 274 277
15. A. Bellacosa, D. de Feo, A.K. Godwin, D.W. Bell, J.Q. Cheng, D.A. Altomare, M. Wan, L. Dubeau, G. Scambia, and V. Masciullo Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas Int. J. Cancer 64 4 1995 280 285
16. C. Benistant, H. Chapuis, and S. Roche A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells Oncogene 19 44 2000 5083 5090
17. T.J. Bos, F.S. Monteclaro, F. Mitsunobu, A.R. Ball Jr., C.H. Chang, T. Nishimura, and P.K. Vogt Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences Genes Dev. 4 10 1990 1677 1687
18. D.K. Broderick, C. Di, T.J. Parrett, Y.R. Samuels, J.M. Cummins, R.E. McLendon, D.W. Fults, V.E. Velculescu, D.D. Bigner, and H. Yan Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas Cancer Res. 64 15 2004 5048 5050
19. G.J. Brunn, C.C. Hudson, A. Sekulic, J.M. Williams, H. Hosoi, P.J. Houghton, J.C. Lawrence Jr., and R.T. Abraham Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin Science 277 5322 1997 99 101
20. P.E. Burnett, R.K. Barrow, N.A. Cohen, S.H. Snyder, and D.M. Sabatini RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 Proc. Natl. Acad. Sci. U.S.A. 95 4 1998 1432 1437
21. D.S. Byun, K. Cho, B.K. Ryu, M.G. Lee, J.I. Park, K.S. Chae, H.J. Kim, and S.G. Chi Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma Int. J. Cancer 104 3 2003 318 327
22. I.G. Campbell, S.E. Russell, D.Y. Choong, K.G. Montgomery, M.L. Ciavarella, C.S. Hooi, B.E. Cristiano, R.B. Pearson, and W.A. Phillips Mutation of the PIK3CA gene in ovarian and breast cancer Cancer Res. 64 21 2004 7678 7681
23. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 5573 2002 1655 1657
24. F. Cavalieri, T. Ruscio, R. Tinoco, S. Benedict, C. Davis, and P.K. Vogt Isolation of three new avian sarcoma viruses: ASV 9, ASV 17, and ASV 25 Virology 143 2 1985 680 683
25. H.W. Chang, M. Aoki, D. Fruman, K.R. Auger, A. Bellacosa, P.N. Tsichlis, L.C. Cantley, T.M. Roberts, and P.K. Vogt Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase Science 276 5320 1997 1848 1850
26. J.Q. Cheng, A.K. Godwin, A. Bellacosa, T. Taguchi, T.F. Franke, T.C. Hamilton, P.N. Tsichlis, and J.R. Testa AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proc. Natl. Acad. Sci. U.S.A. 89 19 1992 9267 9271
27. J.Q. Cheng, B. Ruggeri, W.M. Klein, G. Sonoda, D.A. Altomare, D.K. Watson, and J.R. Testa Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA Proc. Natl. Acad. Sci. U.S.A. 93 8 1996 3636 3641
28. J. Chung, C.J. Kuo, G.R. Crabtree, and J. Blenis Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases Cell 69 7 1992 1227 1236
29. S. Corvera, and M.P. Czech Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction Trends Cell Biol. 8 11 1998 442 446
30. F. Czauderna, M. Fechtner, H. Aygun, W. Arnold, A. Klippel, K. Giese, and J. Kaufmann Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA Nucleic Acids Res. 31 2 2003 670 682
31. P.L. Depowski, S.I. Rosenthal, and J.S. Ross Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer Mod. Pathol. 14 7 2001 672 676
32. B.J. Druker, C.L. Sawyers, H. Kantarjian, D.J. Resta, S.F. Reese, J.M. Ford, R. Capdeville, and M. Talpaz Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N. Engl. J. Med. 344 14 2001 1038 1042
33. V.M. Evdokimova, and L.P. Ovchinnikov Translational regulation by Y-box transcription factor: involvement of the major mRNA-associated protein, p50 Int. J. Biochem. Cell Biol. 31 1 1999 139 149
34. J. Feng, J. Park, P. Cron, D. Hess, and B.A. Hemmings Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase J. Biol. Chem. 279 39 2004 41189 41196
35. L.C. Foukas, and K. Okkenhaug Gene-targeting reveals physiological roles and complex regulation of the phosphoinositide 3-kinases Arch. Biochem. Biophys. 414 1 2003 13 18
36. D.A. Fruman, R.E. Meyers, and L.C. Cantley Phosphoinositide kinases Annu. Rev. Biochem. 67 1998 481 507
37. A. Garami, F.J. Zwartkruis, T. Nobukuni, M. Joaquin, M. Roccio, H. Stocker, S.C. Kozma, E. Hafen, J.L. Bos, and G. Thomas Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 Mol. Cell 11 6 2003 1457 1466
38. A.C. Gingras, S.G. Kennedy, M.A. O'Leary, N. Sonenberg, and N. Hay 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway Genes Dev. 12 4 1998 502 513
39. C. Hartmann, G. Bartels, C. Gehlhaar, N. Holtkamp, and A. von Deimling PIK3CA mutations in glioblastoma multiforme Acta Neuropathol. (Berl.) 109 6 2005 639 642
40. N. Hay, and N. Sonenberg Upstream and downstream of mTOR Genes Dev. 18 16 2004 1926 1945
41. S.H. Hughes, J.J. Greenhouse, C.J. Petropoulos, and P. Sutrave Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors J. Virol. 61 10 1987 3004 3012
42. T. Ikenoue, F. Kanai, Y. Hikiba, T. Obata, Y. Tanaka, J. Imamura, M. Ohta, A. Jazag, B. Guleng, K. Tateishi, Y. Asaoka, M. Matsumura, T. Kawabe, and M. Omata Functional analysis of PIK3CA gene mutations in human colorectal cancer Cancer Res. 65 11 2005 4562 4567
43. K. Inoki, Y. Li, T. Zhu, J. Wu, and K.L. Guan TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling Nat. Cell Biol. 4 9 2002 648 657
44. K. Inoki, Y. Li, T. Xu, and K.L. Guan Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling Genes Dev. 17 15 2003 1829 1834
45. S. Kang, A.G. Bader, and P.K. Vogt Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic Proc. Natl. Acad. Sci. U.S.A. 102 3 2005 802 807
46. S. Kang, A.G. Bader, L. Zhao, and P.K. Vogt Mutated PI 3-kinases: cancer targets on a silver platter Cell Cycle 4 4 2005
47. K. Kohno, H. Izumi, T. Uchiumi, M. Ashizuka, and M. Kuwano The pleiotropic functions of the Y-box-binding protein, YB-1 BioEssays 25 7 2003 691 698
48. H.C. Kolb, M.G. Finn, and K.B. Sharpless Click chemistry: diverse chemical function from a few good reactions Angew Chem., Int. Ed. Engl. 40 11 2001 2004 2021
49. A. Krasinski, Z. Radic, R. Manetsch, J. Raushel, P. Taylor, K.B. Sharpless, and H.C. Kolb In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors J. Am. Chem. Soc. 127 18 2005 6686 6692
50. C.J. Kuo, J. Chung, D.F. Fiorentino, W.M. Flanagan, J. Blenis, and G.R. Crabtree Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase Nature 358 6381 1992 70 73
51. H. Kurosu, T. Maehama, T. Okada, T. Yamamoto, S. Hoshino, Y. Fukui, M. Ui, O. Hazeki, and T. Katada Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110beta is synergistically activated by the betagamma subunits of G proteins and phosphotyrosyl peptide J. Biol. Chem. 272 39 1997 24252 24256
52. J.W. Lee, Y.H. Soung, S.Y. Kim, H.W. Lee, W.S. Park, S.W. Nam, S.H. Kim, J.Y. Lee, N.J. Yoo, and S.H. Lee PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas Oncogene 24 8 2005 1477 1480
53. D.A. Levine, F. Bogomolniy, C.J. Yee, A. Lash, R.R. Barakat, P.I. Borgen, and J. Boyd Frequent mutation of the PIK3CA gene in ovarian and breast cancers Clin. Cancer Res. 11 8 2005 2875 2878
54. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S.H. Bigner, B.C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M.H. Wigler, and R. Parsons PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 5308 1997 1943 1947
55. V.S. Li, C.W. Wong, T.L. Chan, A.S. Chan, W. Zhao, K.M. Chu, S. So, X. Chen, S.T. Yuen, and S.Y. Leung Mutations of PIK3CA in gastric adenocarcinoma BMC Cancer 5 1 2005 29
56. Y. Liao, R. Grobholz, U. Abel, L. Trojan, M.S. Michel, P. Angel, and D. Mayer Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer Int. J. Cancer 107 4 2003 676 680
57. X. Long, Y. Lin, S. Ortiz-Vega, K. Yonezawa, and J. Avruch Rheb binds and regulates the mTOR kinase Curr. Biol. 15 8 2005 702 713
58. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, B.W. Brannigan, P.L. Harris, S.M. Haserlat, J.G. Supko, F.G. Haluska, D.N. Louis, D.C. Christiani, J. Settleman, and D.A. Haber Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 21 2004 2129 2139
59. Y.Y. Ma, S.J. Wei, Y.C. Lin, J.C. Lung, T.C. Chang, J. Whang-Peng, J.M. Liu, D.M. Yang, W.K. Yang, and C.Y. Shen PIK3CA as an oncogene in cervical cancer Oncogene 19 23 2000 2739 2744
60. U. Maier, A. Babich, and B. Nurnberg Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma J. Biol. Chem. 274 41 1999 29311 29317
61. Y. Maki, T.J. Bos, C. Davis, M. Starbuck, and P.K. Vogt Avian sarcoma virus 17 carries the jun oncogene Proc. Natl. Acad. Sci. U.S.A. 84 9 1987 2848 2852
62. R. Manetsch, A. Krasinski, Z. Radic, J. Raushel, P. Taylor, K.B. Sharpless, and H.C. Kolb In situ click chemistry: enzyme inhibitors made to their own specifications J. Am. Chem. Soc. 126 40 2004 12809 12818
63. P.P. Massion, P.M. Taflan, Y. Shyr, S.M. Rahman, P. Yildiz, B. Shakthour, M.E. Edgerton, M. Ninan, J.J. Andersen, and A.L. Gonzalez Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression Am. J. Respir. Crit. Care Med. 170 10 2004 1088 1094
64. Y.H. Min, J.I. Eom, J.W. Cheong, H.O. Maeng, J.Y. Kim, H.K. Jeung, S.T. Lee, M.H. Lee, J.S. Hahn, and Y.W. Ko Constitutive phosphorylation of Akt/PKB protein in acute myeloid leukemia: its significance as a prognostic variable Leukemia 17 5 2003 995 997
65. W. Miwa, J. Yasuda, Y. Murakami, K. Yashima, K. Sugano, T. Sekine, A. Kono, S. Egawa, K. Yamaguchi, Y. Hayashizaki, and T. Sekiya Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer Biochem. Biophys. Res. Commun. 225 3 1996 968 974
66. M. Mizoguchi, C.L. Nutt, G. Mohapatra, and D.N. Louis Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas Brain Pathol. 14 4 2004 372 377
67. V.P. Mocharla, B. Colasson, L.V. Lee, S. Roper, K.B. Sharpless, C.H. Wong, and H.C. Kolb In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II Angew Chem., Int. Ed. Engl. 44 1 2004 116 120
68. C. Murga, S. Fukuhara, and J.S. Gutkind A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt J. Biol. Chem. 275 16 2000 12069 12073
69. K. Nakatani, D.A. Thompson, A. Barthel, H. Sakaue, W. Liu, R.J. Weigel, and R.A. Roth Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines J. Biol. Chem. 274 31 1999 21528 21532
70. B.T. Nave, M. Ouwens, D.J. Withers, D.R. Alessi, and P.R. Shepherd Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation Biochem. J. 344 Pt. 2 1999 427 431
71. S.G. O'Brien, F. Guilhot, R.A. Larson, I. Gathmann, M. Baccarani, F. Cervantes, J.J. Cornelissen, T. Fischer, A. Hochhaus, T. Hughes, K. Lechner, J.L. Nielsen, P. Rousselot, J. Reiffers, G. Saglio, J. Shepherd, B. Simonsson, A. Gratwohl, J.M. Goldman, H. Kantarjian, K. Taylor, G. Verhoef, A.E. Bolton, R. Capdeville, and B.J. Druker Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia N. Engl. J. Med. 348 11 2003 994 1004
72. K. Okkenhaug, and B. Vanhaesebroeck PI3K in lymphocyte development, differentiation and activation Nat. Rev., Immunol. 3 4 2003 317 330
73. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M.J. Eck, W.R. Sellers, B.E. Johnson, and M. Meyerson EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 5676 2004 1497 1500
74. W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi, I. Sarkaria, B. Singh, R. Heelan, V. Rusch, L. Fulton, E. Mardis, D. Kupfer, R. Wilson, M. Kris, and H. Varmus EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib Proc. Natl. Acad. Sci. U.S.A. 101 36 2004 13306 13311
75. T. Patschinsky, H.W. Jansen, H. Blocker, R. Frank, and K. Bister Structure and transforming function of transduced mutant alleles of the chicken c-myc gene J. Virol. 59 2 1986 341 353
76. J.M. Pedrero, D.G. Carracedo, C.M. Pinto, A.H. Zapatero, J.P. Rodrigo, C.S. Nieto, and M.V. Gonzalez Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma Int. J. Cancer 114 2 2005 242 248
77. S. Persad, S. Attwell, V. Gray, N. Mawji, J.T. Deng, D. Leung, J. Yan, J. Sanghera, M.P. Walsh, and S. Dedhar Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343 J. Biol. Chem. 276 29 2001 27462 27469
78. D.J. Price, J.R. Grove, V. Calvo, J. Avruch, and B.E. Bierer Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase Science 257 5072 1992 973 977
79. B.A. Ruggeri, L. Huang, M. Wood, J.Q. Cheng, and J.R. Testa Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas Mol. Carcinog. 21 2 1998 81 86
80. L.H. Saal, K. Holm, M. Maurer, L. Memeo, T. Su, X. Wang, J.S. Yu, P.O. Malmstrom, M. Mansukhani, J. Enoksson, H. Hibshoosh, A. Borg, and R. Parsons PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma Cancer Res. 65 7 2005 2554 2559
81. Y. Samuels, Z. Wang, A. Bardelli, N. Silliman, J. Ptak, S. Szabo, H. Yan, A. Gazdar, S.M. Powell, G.J. Riggins, J.K. Willson, S. Markowitz, K.W. Kinzler, B. Vogelstein, and V.E. Velculescu High frequency of mutations of the PIK3CA gene in human cancers Science 304 5670 2004 554
82. D.D. Sarbassov, D.A. Guertin, S.M. Ali, and D.M. Sabatini Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 307 5712 2005 1098 2101
83. L.J. Saucedo, X. Gao, D.A. Chiarelli, L. Li, D. Pan, and B.A. Edgar Rheb promotes cell growth as a component of the insulin/TOR signalling network Nat. Cell Biol. 5 6 2003 566 571
84. A. Sekulic, C.C. Hudson, J.L. Homme, P. Yin, D.M. Otterness, L.M. Karnitz, and R.T. Abraham A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells Cancer Res. 60 13 2000 3504 3513
85. J. Shaw, M.J. Hayman, and P.J. Enrietto Analysis of a deleted MC29 provirus: gag sequences are not required for fibroblast transformation J. Virol. 56 3 1985 943 950
86. L. Shayesteh, Y. Lu, W.L. Kuo, R. Baldocchi, T. Godfrey, C. Collins, D. Pinkel, B. Powell, G.B. Mills, and J.W. Gray PIK3CA is implicated as an oncogene in ovarian cancer Nat. Genet. 21 1 1999 99 102
87. H.M. Shepard, G.D. Lewis, J.C. Sarup, B.M. Fendly, D. Maneval, J. Mordenti, I. Figari, C.E. Kotts, M.A. Palladino Jr., and A. Ullrich Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic J. Clin. Immunol. 11 3 1991 117 127
88. S.P. Staal Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma Proc. Natl. Acad. Sci. U.S.A. 84 14 1987 5034 5037
89. L. Stephens, K. Anderson, D. Stokoe, H. Erdjument-Bromage, G.F. Painter, A.B. Holmes, P.R. Gaffney, C.B. Reese, F. McCormick, P. Tempst, J. Coadwell, and P.T. Hawkins Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B Science 279 5351 1998 710 714
90. D. Stokoe, L.R. Stephens, T. Copeland, P.R. Gaffney, C.B. Reese, G.F. Painter, A.B. Holmes, F. McCormick, and P.T. Hawkins Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B Science 277 5325 1997 567 570
91. P. Sujobert, V. Bardet, P. Cornillet-Lefebvre, J.S. Hayflick, N. Prie, F. Verdier, B. Vanhaesebroeck, O. Muller, F. Pesce, N. Ifrah, M. Hunault-Berger, C. Berthou, B. Villemagne, E. Jourdan, B. Audhuy, E. Solary, B. Witz, J.L. Harousseau, C. Himberlin, T. Lamy, B. Lioure, J.Y. Cahn, F. Dreyfus, P. Mayeux, C. Lacombe, and D. Bouscary Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia Blood 106 3 2005 1063 1066
92. A.R. Tee, B.D. Manning, P.P. Roux, L.C. Cantley, and J. Blenis Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb Curr. Biol. 13 15 2003 1259 1268
93. A. Toker, and A.C. Newton Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site J. Biol. Chem. 275 12 2000 8271 8274
94. H. Tsuchie, C.H. Chang, M. Yoshida, and P.K. Vogt A newly isolated avian sarcoma virus, ASV-1, carries the crk oncogene Oncogene 4 11 1989 1281 1284
95. B. Vanhaesebroeck, and M.D. Waterfield Signaling by distinct classes of phosphoinositide 3-kinases Exp. Cell Res. 253 1 1999 239 254
96. B. Vanhaesebroeck, S.J. Leevers, G. Panayotou, and M.D. Waterfield Phosphoinositide 3-kinases: a conserved family of signal transducers Trends Biochem. Sci. 22 7 1997 267 272
97. M.F. Verderame, T.D. Nelle, and J.W. Wills The membrane-binding domain of the Rous sarcoma virus Gag protein J. Virol. 70 4 1996 2664 2668
98. E.H. Walker, O. Perisic, C. Ried, L. Stephens, and R.L. Williams Structural insights into phosphoinositide 3-kinase catalysis and signalling Nature 402 6759 1999 313 320
99. Y. Wang, A. Helland, R. Holm, G.B. Kristensen, and A.L. Borresen-Dale PIK3CA mutations in advanced ovarian carcinomas Hum. Mutat. 25 3 2005 322
100. J.W. Wills, R.C. Craven, R.A. Weldon Jr., T.D. Nelle, and C.R. Erdie Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src J. Virol. 65 7 1991 3804 3812
101. M.P. Wymann, M. Zvelebil, and M. Laffargue Phosphoinositide 3-kinase signalling-Which way to target? Trends Pharmacol. Sci. 24 7 2003 366 3676
102. D. Yu, and M.C. Hung Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 19 53 2000 6115 6121
103. Y. Zhang, X. Gao, L.J. Saucedo, B. Ru, B.A. Edgar, and D. Pan Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins Nat. Cell Biol. 5 6 2003 578 581